Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 51-60 of 65

Page
per page
  1. Ro 3306
    A8885 Ro 3306
     4 Citation
    Target: Cyclin-Dependent Kinases
    Summary: An ATP-competitive, potent CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  2. Entacapone
    A4168 Entacapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
  3. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  4. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  5. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  6. Nocodazole
    A8487 Nocodazole
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Tubulin production inhibitor,anti-neoplastic agent
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  7. Saxagliptin
    A8650 Saxagliptin
    Target: DPP-4
    Summary: Selective DPP4 inhibitor
  8. GlyH-101
    B1087 GlyH-101
    Target: CFTR
    Summary: CFTR Inhibitor II
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  9. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  10. Bivalirudin Trifluoroacetate
    A3244 Bivalirudin Trifluoroacetate
    Target: thrombin
    Summary: Reversible thrombin inhibitor
      ≥54.5 mg/mL

Items 51-60 of 65

Page
per page
Shop By
Now Shopping by
  1. Reversibility Reversible Remove This Item
Clear All
Shopping Options
Specificity
  1. Selective 54item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 2item
  3. Proteasome 3item
  4. Cathepsins 4item
  5. Histone Deacetylases (HDACs) 2item
  6. Akt 1 item
  7. PI3K 2item
  8. CXCR 1 item
  9. Raf 1 item
  10. Aurora Kinases 2item
  11. mTOR 1 item
  12. MMP 1 item
  13. Myosin II ATPases 1 item
  14. Factor Xa 1 item
  15. PLK 1 item
  16. Chk 1 item
  17. JNK 1 item
  18. MEK 1 item
  19. Deubiquitinating enzymes (DUBs) 1 item
  20. Src 1 item
  21. NMDA Receptors 1 item
  22. Microtubules/Tubulins 2item
  23. EGFR 2item
  24. FAK 3item
  25. JAK 2item
  26. Syk 1 item
  27. AMPK 1 item
  28. S-nitrosoglutathione reductase 1 item
  29. CFTR 1 item
  30. thrombin 1 item
  31. ErbB 2item
  32. Actin 1 item
  33. ERK 1 item
  34. PKC 1 item
  35. Calpains 1 item
  36. SMYD2 1 item
  37. RAD51 1 item
  38. Trypsins 1 item
  39. Pyk2 3item
  40. Insulin and Insulin-like Receptors 1 item
  41. ALK 1 item
  42. GTPases 1 item
  43. CETP 1 item
  44. PKA 1 item
  45. Myosin light chain kinases (MLCKs) 1 item
  46. MK2 1 item
  47. ATM/ATR 1 item
  48. AChE 1 item
  49. ZAP-70 1 item
  50. Catechol O-Methyltransferase (COMT) 1 item
  51. DPP-4 1 item
  52. Dipeptidyl-peptidase II 1 item
  53. P97 ATPase 1 item
  54. Aromatases 1 item
  55. UCH 1 item
  56. MST 1 item
  57. ATM 1 item
Reported Experiments
  1. Animal Experiments 54item
  2. Cell Experiments 34item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Breast Cancer 9item
  4. Cancer 28item
  5. Colon Cancer 3item
  6. Colorectal Cancer 2item
  7. Diabetes 1 item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. Hepatocellular Carcinoma 2item
  11. Hypercholesterolemia 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 2item
  14. Lung Cancer 2item
  15. Lymphoma 1 item
  16. Mantle Cell Lymphoma 1 item
  17. Multiple Myeloma 1 item
  18. Pancreatic Cancer 4item
  19. Psoriasis 1 item
  20. Renal Cancer 1 item
  21. Rheumatoid Arthritis 1 item